Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
NCT ID: NCT05673681
Last Updated: 2023-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
7000 participants
OBSERVATIONAL
2022-06-01
2032-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To describe socioeconomical individual risk factors associated with melanoma prognosis, such as gender, residence area or socioeconomic level.
* To describe potentially modifiable characteristics of health care associated with prognosis, such as waiting times, type of centre that makes the diagnosis or use of teledermatology Participants data will be gathered for analysis, without any change in the way that they are being treated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
NCT03605771
Multicentric Cohort of Melanoma Patients in Ile de France Area
NCT00839410
Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor.
NCT04625491
Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database
NCT05426239
Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
NCT06994208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* non-cutaneous melanomas,
* metastatic melanoma with unknown primary site.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación Academia Española de Dermatología
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain
Complexo Hospitalario Universitario de A Coruña
A Coruña, , Spain
Hospital Clinic
Barcelona, , Spain
Hospital San Juan de Dios
Córdoba, , Spain
Hospital Universitario de Gran Canaria Dr Negrín
Las Palmas, , Spain
Complejo Asistencial Universitario de León
León, , Spain
Clínica Dermatológica Internacional
Madrid, , Spain
Clínica Universitaria de Navarra ( sede de Madrid)
Madrid, , Spain
Hospital Clínico San Carlos
Madrid, , Spain
Hospital La Paz
Madrid, , Spain
Hospital Puerta de Hierro Majadahonda
Madrid, , Spain
Ruber Internacional
Madrid, , Spain
Hospital Central de Asturias
Oviedo, , Spain
Hospital Son LLàtzer
Palma de Mallorca, , Spain
Complexo Hospitalario Universitario de Pontevedra
Pontevedra, , Spain
H.U. Nuestra Señora de la Candelaria
Santa Cruz de Tenerife, , Spain
Hospital Universitario Virgen Macarena de Sevilla
Seville, , Spain
Quirón Salud Sevilla
Seville, , Spain
Hospital La Fé
Valencia, , Spain
Instituto Valenciano de Oncología
Valencia, , Spain
Hospital Miguel Servet
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Aram Boada, MD
Role: primary
Sabela Paradela
Role: primary
Susana Puig, PhD
Role: primary
Antonio Tejera, PhD
Role: primary
Elena Castro, MD
Role: primary
Elia Samaniego González, MD
Role: primary
Pedro Rodríguez Jiménez
Role: primary
Alejandra Tomás Velázquez
Role: primary
Alberto Conde Taboada, PhD
Role: primary
Ander Mayor
Role: primary
Gastón Roustan
Role: primary
Pedro Rodríguez Jiménez
Role: primary
Cayetana Maldonado
Role: primary
Rosa Taberner
Role: primary
Ángeles Flórez
Role: primary
Ricardo Fernandez de Misa Cabrera
Role: primary
Lara Ferrándiz
Role: primary
Tomás Toledo Pastrana
Role: primary
Rafael Botella
Role: primary
Eduardo Nagore Enguidanos, PhD
Role: primary
Yolanda Gilaberte
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAE-MEL-2022-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.